Driving Restrictions Beyond 1 Month After CAR-T Therapy Not Needed for All Patients, Researchers Say
Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.
Childhood cancer survivors “may experience considerable accelerated aging throughout their lifespan,” the researchers wrote.
Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.
Barriers to wider use of AI in oncology include inaccuracy, workflow challenges, environmental impacts, and more.
The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.
High intake of sugar-sweetened beverages is associated with an increased risk of oral cavity cancer in women, data suggest.
Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.
Ocular AEs linked to mirvetuximab soravtansine do not appear to reduce HRQOL in patients with FRα+ platinum-resistant ovarian cancer.
Study results suggest that “telemedicine represents a unique opportunity to reduce time and travel burdens for patients with cancer considering clinical trials,” according to researchers.
This article highlights women who have made major contributions to the field of medicine throughout history. Historically, women have faced barriers to entering the field of medicine, being ...
(HealthDay News) — The Oklahoma State Department of Health has reported 4 probable cases of measles, all in unvaccinated individuals. A total of 321 measles cases have been reported since the ...
The conversion from accelerated approval to traditional approval was supported by data from the phase 3 KEYNOTE-811 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results